Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
2.130
+0.010 (0.47%)
At close: Jun 29, 2025

EGX:MCRO Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,1971,3231,6821,870--
Market Cap Growth
-18.18%-21.36%-10.06%---
Enterprise Value
1,3831,4751,8151,944--
Last Close Price
2.132.322.953.18--
PE Ratio
19.47--10.76--
Forward PE
-10.0710.0710.07--
PS Ratio
1.862.543.202.56--
PB Ratio
11.9116.9417.834.04--
P/TBV Ratio
16.3525.8425.104.56--
P/FCF Ratio
---14.43--
P/OCF Ratio
---13.86--
PEG Ratio
-0.420.420.42--
EV/Sales Ratio
2.142.843.452.66--
EV/EBITDA Ratio
11.4788.83-8.17--
EV/EBIT Ratio
12.98122.57-8.30--
EV/FCF Ratio
-61.45--15.00--
Debt / Equity Ratio
3.384.052.400.440.270.26
Debt / EBITDA Ratio
2.8211.06-0.830.470.35
Debt / FCF Ratio
---1.582.201.64
Asset Turnover
1.130.920.771.021.21-
Inventory Turnover
1.901.611.641.642.15-
Quick Ratio
0.580.360.291.181.191.18
Current Ratio
1.651.351.082.002.312.06
Return on Equity (ROE)
90.16%-44.13%-97.85%42.37%48.77%-
Return on Assets (ROA)
11.63%1.33%-16.72%20.53%25.81%-
Return on Capital (ROIC)
19.87%2.10%-23.07%26.08%33.12%-
Return on Capital Employed (ROCE)
30.80%5.20%-48.50%54.90%72.40%
Earnings Yield
5.21%-2.88%-16.21%9.29%--
FCF Yield
-1.88%-6.56%-2.64%6.93%--
Dividend Yield
---3.36%--
Payout Ratio
7.54%--23.01%31.65%54.65%
Buyback Yield / Dilution
-1.17%-1.12%1.46%0.88%--
Total Shareholder Return
--1.12%1.46%4.24%--
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.